RAASY
Cloopen Group Holding Ltd
$2.10
-0.47%
No data for this timeframe.
Vol
SEC Reports3
Recent Activity
May 12, 2026
SEC
Cloopen Group Holding Limited announced a definitive merger agreement to go private at US$2.9641 per ADS (110.22% premiu
6-K — Impact 8/10
May 8, 2026
SEC
Cloopen Group filed its annual report on Form 20-F for FY2025, confirming a 6.6% revenue decline to RMB535.7M and a wide
6-K — Impact 2/10
May 8, 2026
SEC
Cloopen Group Holding Ltd filed its annual report on Form 20-F for the fiscal year ended December 31, 2025, reporting a
20-F — Impact 7/10
Analyst Ratings
3Strong Buy
5Buy
1Hold
0Sell
0Strong Sell
Latest Reports
BULLISH
6-K
8/10
Cloopen Group Holding Limited announced a definitive merger agreement to go private at US$2.9641 per ADS (110.22% premiu
May 12, 2026
NEUTRAL
6-K
2/10
Cloopen Group filed its annual report on Form 20-F for FY2025, confirming a 6.6% revenue decline to RMB535.7M and a wide
May 8, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
3 SEC filing reports analyzed. Sentiment: 1 bullish, 1 bearish, 0 mixed, 1 neutral. Avg impact: 5.7/10.
BULLISH
6-K
8/10
Cloopen Group Holding Limited announced a definitive merger agreement to go private at US$2.9641 per
May 12, 2026
NEUTRAL
6-K
2/10
Cloopen Group filed its annual report on Form 20-F for FY2025, confirming a 6.6% revenue decline to
May 8, 2026
BEARISH
20-F
7/10
Cloopen Group Holding Ltd filed its annual report on Form 20-F for the fiscal year ended December 31
May 8, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 89% buy across 9 analysts — 3 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2021-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Dec 1, 2022 | 3 | 5 | 1 | 0 | 0 | 89% | |
| Nov 1, 2022 | 3 | 5 | 1 | 0 | 0 | 89% | |
| Oct 1, 2022 | 3 | 5 | 1 | 0 | 0 | 89% | |
| Sep 1, 2022 | 3 | 5 | 1 | 0 | 0 | 89% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.